Objective We aimed to examine the association of apolipoprotein E (APOE) ε4 genotype with neuroimaging markers of Alzheimer’s disease: hippocampal volume brain amyloid deposition and cerebral metabolism. carrier status was associated with atrophic hippocampal volume (pooled SMD: ?0.47; 95% CI ?0.82 to ?0.13; p=0.007) and increased cerebral amyloid positron emission tomography tracer (pooled SMD: 0.62… Continue reading Objective We aimed to examine the association of apolipoprotein E (APOE)